13F-HR filed by Pivotal bioVenture Partners Investment Advisor LLC
Pivotal bioVenture Partners Investment Advisor LLC filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-10, with 11 holding rows worth $273,655,000.
- Accession
- 0001012975-22-000484
- Filer
- CIK 1844645
- Filed
- 2022-11-10
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2022
A holdings report, 11 entries on the cover page, a total value of $273,655,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $273,655,000 with VALUE read as thousands by filing date, 13F file number 028-20630. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerPivotal bioVenture Partners Fund I U.G.P., Ltd028-20631
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 765,895 | $172,273,000 | thousands by filing date | |
| RALLYBIO CORP | 75120L100 | COM | 2,271,311 | $32,866,000 | thousands by filing date | |
| VAXCYTE INC COM | 92243G108 | Stock | 776,039 | $18,625,000 | thousands by filing date | |
| AKOUOS INC | 00973J101 | COM | 1,794,088 | $12,128,000 | thousands by filing date | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 569,041 | $10,874,000 | thousands by filing date | |
| INOZYME PHARMA INC | 45790W108 | COM | 2,661,154 | $7,132,000 | thousands by filing date | |
| EXSCIENTIA PLC | 30223G102 | ADS | 772,285 | $6,340,000 | thousands by filing date | |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 560,595 | $5,101,000 | thousands by filing date | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 1,560,984 | $4,699,000 | thousands by filing date | |
| BOLT BIOTHERAPEUTICS INC | 097702104 | COM | 1,891,467 | $2,799,000 | thousands by filing date | |
| ALIGOS THERAPEUTICS INC COM NEW | 01626L105 | Stock | 743,215 | $818,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001012975-22-000484 | this filing | 2022-11-10 | acceptance time not in the bulk data set |